Drug factory · FDA FEI 3002929455

Catalent CTS, LLC

10245 Hickman Mills Dr, Kansas City, MO, United States

United States: 1

No problems found at FDA's last inspection, Mar 4, 2022.

No Action Indicated: inspectors found no objectionable conditions.

8 drug inspections on record since 2010: 6 with no problems, 2 with problems fixed voluntarily, 0 with FDA action.

What it does, for whom

DrugRoleForNDC
CabozantinibMakes it, tests it, packages it and labels it Exelixis, Inc. 42388-011, 42388-012, 42388-013
DanicopanMakes it, tests it, packages it and labels it Catalent Pharma Solutions, LLC 11014-0739
DiclofenacMakes it Iroko Pharmaceuticals, LLC 42211-203, 42211-204
DuvelisibMakes it and tests it Secura Bio, Inc., Verastem, Inc. 73116-215, 73116-225, 71779-115 +1
GemcitabineMakes it, tests it and packages it Janssen Biotech, Inc. 57894-225
MaribavirMakes it, tests it, packages it and labels it Takeda Pharmaceuticals America, Inc. 64764-800
MeloxicamMakes it Iroko Pharmaceuticals, LLC 42211-205, 42211-206
SparsentanMakes it Travere Therapeutics, Inc. 68974-200, 68974-400
ZanubrutinibMakes it and tests it BeOne Medicines USA, Inc. 72579-011

FDA inspection history

EndedResultProgramProblems noted
Mar 4, 2022No problems foundDrug Quality Assurance—
Nov 6, 2017No problems foundDrug Quality Assurance—
Jun 29, 2015No problems foundDrug Quality Assurance—
Nov 10, 2014Problems found, fixed voluntarilyDrug Quality Assurance—
Mar 5, 2014No problems foundDrug Quality Assurance—
Jan 14, 2013No problems foundDrug Quality Assurance—
Jun 8, 2012No problems foundDrug Quality Assurance—
Mar 24, 2010Problems found, fixed voluntarilyDrug Quality Assurance—

Registered with FDA for: analysis; label; manufacture; pack.